{"id":"7f434d95c81c","type":"article","url":"https://hartvaat.nl/2026/02/20/mhealth-interventie-verbetert-hypertensiezorg-bij-hoogrisicopatienten/","title":"mHealth-interventie verbetert hypertensiezorg bij hoogrisicopatiënten","title_en":"mHealth Intervention to Improve Hypertension Care in High-Risk Patients","category":"hypertensie","category_label":"Hypertensie","professions":["huisarts"],"tags":["acuut-hartfalen","bloeddrukbehandeling","digitale-gezondheid","farmaco-economie","holter","summit-trial","thuisbloeddrukmeting","vrouwen"],"journal":"Hypertension","doi":"https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26148","source_url":"https://doi.org/https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26148","authors":["Kamakshi Lakshminarayan"],"significance":7,"published":"2026-02-20","source_date":"2026-02-20","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/bloeddrukmeting-thuismeting-abpm/","https://hartvaat.nl/kennis/hypertensie/hypertensie-en-ckd/"],"congress":"","summary_en":"The mGlide trial showed that a pharmacist-led, mobile health technology-facilitated care model improves blood pressure control in diverse patients with uncontrolled hypertension, demonstrating the effectiveness of technology-enabled interprofessional care.","created":"2026-07-03T10:24:59Z","updated":"2026-07-03T18:38:09Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"De mGlide-trial onderzocht een apothekergeleid zorgmodel met mobiele gezondheidstechnologie bij diverse patiënten met ongecontroleerde hypertensie. De interventie omvatte dagelijkse bloeddrukmeting via smartphone, automatische datadeling en farmaceutische begeleiding.","abstract_original":"Hypertension, Volume 83, Issue 4, Page e26148, April 1, 2026. BACKGROUND:The mGlide RCT (randomized controlled trial) evaluated whether a pharmacist-led, mobile health technology facilitated care model improves hypertension control in diverse populations.METHODS:We recruited adult English, Spanish, or Hmong-speaking patients with uncontrolled hypertension from a large health care system and smaller community clinics serving low-income patients. Participants were randomized 1:1 to mGlide or usual care. The 6-month intervention included daily blood pressure (BP) self-monitoring using a smartphone and wireless monitor, automated app-based data sharing, and responsive medication adjustment by a pharmacist-led provider-team. Comparison participants received a digital monitor. Outcomes included mean 6-month systolic BP (SBP), 12-month sustained BP control, 24-hour ambulatory BP and patient activation.RESULTS:A total of 395 participants (mean age, 66.9 years; 46.6% women; mean [SD] SBP, 143.4"}